37 related articles for article (PubMed ID: 3034934)
1. Molecular biology of lung cancer: clinical implications.
Larsen JE; Minna JD
Clin Chest Med; 2011 Dec; 32(4):703-40. PubMed ID: 22054881
[TBL] [Abstract][Full Text] [Related]
2. Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?
Campling BG; Baer K; Baker HM; Lam YM; Cole SP
Br J Cancer; 1993 Aug; 68(2):327-35. PubMed ID: 8102244
[TBL] [Abstract][Full Text] [Related]
3. Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.
Slebos RJ; Evers SG; Wagenaar SS; Rodenhuis S
Br J Cancer; 1989 Jan; 59(1):76-80. PubMed ID: 2547415
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity testing of small cell lung cancer using the MTT assay.
Campling BG; Pym J; Baker HM; Cole SP; Lam YM
Br J Cancer; 1991 Jan; 63(1):75-83. PubMed ID: 1846554
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance-associated antigens on drug-sensitive and -resistant human tumour cell lines.
Mirski SE; Cole SP
Br J Cancer; 1991 Jul; 64(1):15-22. PubMed ID: 1677258
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line.
Cardona C; Bleehen NM; Reeve JG
Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):115-20. PubMed ID: 1310003
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer.
Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA
Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004
[TBL] [Abstract][Full Text] [Related]
8. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
9. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
10. Genome analysis of small cell lung cancer (SCLC) and clinical significance.
Buys CH; Osinga J; van der Veen AY; Mooibroek H; van der Hout AH; de Leij L; Postmus PE; Carritt B
Eur J Respir Dis Suppl; 1987; 149():29-36. PubMed ID: 3034645
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and a specific chromosomal abnormality associated with small-cell lung cancers.
Taya Y
Jpn J Clin Oncol; 1986 Sep; 16(3):199-202. PubMed ID: 3022029
[TBL] [Abstract][Full Text] [Related]
12. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
13. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
14. Oncogene amplification and chromosomal abnormalities in small cell lung cancer.
Ibson JM; Waters JJ; Twentyman PR; Bleehen NM; Rabbitts PH
J Cell Biochem; 1987 Apr; 33(4):267-88. PubMed ID: 3034934
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
